Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol (JOTROLTM) in Parkinson's Disease
NCT07592767Phase 2Recruiting
- Sponsor
- Georgetown University
- Start
- Sep 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of resveratrol in Parkinson's disease (PD), sponsored by Georgetown University. Started Sep 2026; status: recruiting.
02
Drugs
resveratrol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07592767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07592767.